Search - tctmd.com

Displaying 1 - 20 of 80

Sort: Relevancy | Date

TCTMD’s Top 10 Most Popular Stories for November 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for November 2021

November 30, 2021

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

News Conference News PCR London Valves 2021

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

Michael O'Riordan

November 25, 2021

US Aortic Valve Trends in Older Patients Hint at Better Outcomes, Access

News Daily News

US Aortic Valve Trends in Older Patients Hint at Better Outcomes, Access

November 23, 2021

Lariat LAA Ligation Doesn’t Boost Effect of AF Ablation: aMAZE Trial

News Conference News AHA 2021

Lariat LAA Ligation Doesn’t Boost Effect of AF Ablation: aMAZE Trial

November 18, 2021

PALACS: Posterior Left Pericardiotomy Cuts Postop AF After Cardiac Surgery

News Conference News AHA 2021

PALACS: Posterior Left Pericardiotomy Cuts Postop AF After Cardiac Surgery

November 14, 2021

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

News Conference News AHA 2021

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

November 13, 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

November 08, 2021

EXPAND G4: Core Laboratory Echocardiographic Outcomes From a Multicenter Study of a Fourth Generation TEER System to Treat Mitral Regurgitation

Presentation TCT 2021

EXPAND G4: Core Laboratory Echocardiographic Outcomes From a Multicenter Study of a Fourth Generation TEER System to Treat Mitral Regurgitation

Presenter: Evelio Rodriguez

November 06, 2021

Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter?

News Conference News TCT 2021

Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter?

November 06, 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

Outcomes of Repeat TAVR According to the Initial and Subsequent TAVR Type

Presentation TCT 2021

Outcomes of Repeat TAVR According to the Initial and Subsequent TAVR Type

Presenter: Uri Landes

November 04, 2021

Outcomes of Repeat TAVR With Balloon-Expandable Sapien 3/Ultra Valves

Presentation TCT 2021

Outcomes of Repeat TAVR With Balloon-Expandable Sapien 3/Ultra Valves

Presenter: Raj Makkar

November 04, 2021

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

News Daily News

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

Yael L. Maxwell

November 02, 2021

November 2021 News Roundup

News Opinion CV Team Dispatch

November 2021 News Roundup

November 01, 2021

More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients

News Conference News EACTS 2021

More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients

Michael O'Riordan

October 18, 2021

Half-Dose DOAC May Be a Good Post-Watchman Option

News Daily News

Half-Dose DOAC May Be a Good Post-Watchman Option

October 14, 2021

Failed MitraClip Is Uncommon, but Bleak When It Happens

News Conference News TCT 2021

Failed MitraClip Is Uncommon, but Bleak When It Happens

Michael O'Riordan

October 08, 2021

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

News Conference News TCT 2021

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

Michael O'Riordan

October 07, 2021

SWEDEHEART Data Reassure on 10-Year Survival for TAVI Patients With Pacemakers

News Daily News

SWEDEHEART Data Reassure on 10-Year Survival for TAVI Patients With Pacemakers

October 05, 2021

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

News Daily News

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

Michael O'Riordan

October 01, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.